1. Search Result
Search Result
Results for "

2171511-58-1

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P9977
    Amivantamab

    JNJ-61186372

    EGFR Cancer
    Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells.